XBiotech Inc.
XBIT
$2.95
-$0.19-6.05%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 927.00K | 777.00K | 1.98M | 1.03M | 783.00K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.75M | 7.90M | 14.97M | 10.85M | 8.59M |
Operating Income | -8.75M | -7.90M | -14.97M | -10.85M | -8.59M |
Income Before Tax | -10.55M | -5.01M | -13.03M | -9.98M | -4.73M |
Income Tax Expenses | -41.00K | 9.00K | -25.00K | 25.00K | -99.00K |
Earnings from Continuing Operations | -10.51M | -5.02M | -13.01M | -10.00M | -4.64M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -10.51M | -5.02M | -13.01M | -10.00M | -4.64M |
EBIT | -8.75M | -7.90M | -14.97M | -10.85M | -8.59M |
EBITDA | -8.31M | -7.47M | -14.53M | -10.42M | -8.15M |
EPS Basic | -0.34 | -0.16 | -0.43 | -0.33 | -0.15 |
Normalized Basic EPS | -0.22 | -0.10 | -0.27 | -0.20 | -0.10 |
EPS Diluted | -0.34 | -0.16 | -0.43 | -0.33 | -0.16 |
Normalized Diluted EPS | -0.22 | -0.10 | -0.27 | -0.20 | -0.10 |
Average Basic Shares Outstanding | 30.47M | 30.47M | 30.46M | 30.44M | 30.44M |
Average Diluted Shares Outstanding | 30.47M | 30.47M | 30.46M | 30.44M | 30.44M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |